Invesco S&P MidCap 400 Revenue ETF (NYSEARCA:RWK) Shares Down 0.7% – Time to Sell?

Invesco S&P MidCap 400 Revenue ETF (NYSEARCA:RWK) fell 0.7% during trading on Thursday. The company traded as low as $140.08 and last traded at $140.56. Approximately 28,375 shares traded hands during mid-day trading, an increase of 39% from the average daily volume of 20,468 shares. The stock had previously closed at $141.53.

Invesco S&P MidCap 400 Revenue ETF Price Performance

The firm’s 50 day simple moving average is $147.73 and its 200-day simple moving average is $141.53. The company has a market cap of $1.28 billion, a price-to-earnings ratio of 14.05 and a beta of 1.06.

Institutional Trading of Invesco S&P MidCap 400 Revenue ETF

Large investors have recently made changes to their positions in the company. Trust Co. of Vermont purchased a new position in Invesco S&P MidCap 400 Revenue ETF during the 2nd quarter worth approximately $135,000. Essex Financial Services Inc. purchased a new stake in Invesco S&P MidCap 400 Revenue ETF in the first quarter valued at approximately $202,000. Kingsview Wealth Management LLC purchased a new stake in Invesco S&P MidCap 400 Revenue ETF in the fourth quarter valued at approximately $358,000. Fifth Third Bancorp acquired a new stake in shares of Invesco S&P MidCap 400 Revenue ETF in the first quarter valued at approximately $377,000. Finally, Nations Financial Group Inc. IA ADV boosted its holdings in shares of Invesco S&P MidCap 400 Revenue ETF by 27.5% in the first quarter. Nations Financial Group Inc. IA ADV now owns 2,949 shares of the company’s stock valued at $378,000 after acquiring an additional 636 shares during the period.

Invesco S&P MidCap 400 Revenue ETF Company Profile

RevenueShares Mid Cap ETF (the Fund) seeks to achieve its investment objective of outperforming the total return performance of the S&P MidCap 400 Index (S&P 400) by investing in the constituent securities of the S&P 400 in the same proportions as the RevenueShares Mid Cap Index. The Fund consists of the same constituent securities as the S&P 400. But rather than being weighted by market capitalization, the Fund employs a patent-pending investment methodology to weight stocks by annual revenue. The Fund is rebalanced annually.